688799 Hunan Warrant Pharmaceutical
- 47.80
- +4.00+9.13%
Hunan Warrant Pharmaceutical News
Voluntary disclosure of the announcement that the subsidiary ZG-001 Capsule completed phase I clinical trials and signed a cooperation framework agreement
Warner Pharmaceuticals: Announcement on participating in the 2024 Investor Online Group Reception Day in Hunan
Announcement on participating in the 2024 Investor Online Group Reception Day event in Hunan
Legal Opinion of Beijing Kangda Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hunan Warner Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Warner Pharmaceuticals Investor Relations Activity Record Form (2024 Semi-Annual Science and Technology Innovation Board Pharmaceutical and Biological Products Group Performance Briefing)
SDIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Hunan Warner Pharmaceutical Co., Ltd.
2024 Second Extraordinary General Meeting of Shareholders Meeting Meeting Materials
Warner Pharmaceuticals Investor Relations Activity Record Form (September 9, September 10, 2024)
Announcement on attending the 2024 Semi-Annual Science and Technology Innovation Board Special Group Results Briefing on Pharmaceuticals and Biological Products
Corrective notice to the announcement of the resolution of the 11th meeting of the 3rd Board of Supervisors
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Warner Pharmaceuticals Investor Relations Activity Record Form (August 31, 2024)
Notice on Acknowledging the Use of Some Temporarily Idle Raised Funds for Cash Management
2024 Semi-Annual Report
Special Report on the Deposit and Actual Use of Funds Raised for the Semiannual Year of 2024
Announcement of Resolutions of the 11th Meeting of the Third Board of Directors
Semi-annual Evaluation Report on the 2024 Action Plan to Improve Quality, Increase Efficiency, and Value Rewards
2024 Semi-Annual Report Summary
Tianjian Certified Public Accountants (Special General Partnership) Special Audit Report on Changes in Accounting Estimates of Hunan Warner Pharmaceutical Co., Ltd.
Analysis
Price Target
No Data
No Data